Qol Holdings Co (TSE:3034) EBIT: 円14,746 Mil (TTM As of Mar. 2026)


TSE:3034 Qol Holdings Co Ltd TSE:3034
89 GF Score
Price 円1,822.00
GF Value 円2,274.64
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Qol Holdings Co EBIT?

Qol Holdings Co TSE:3034 +0.11% 89 EBIT is 円14,746 Mil as of Mar. 2026. GuruFocus rates TSE:3034 with a GF Score™ of 89/100 and a GF Value™ of 円2,274.64 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Qol Holdings Co's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was 円5,111 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was 円14,746 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Qol Holdings Co's annualized ROC % for the quarter that ended in Mar. 2026 was 10.40%. Qol Holdings Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 102.06%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Qol Holdings Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 16.96%.

Qol Holdings Co  (TSE:3034) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Qol Holdings Co's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=21584 * ( 1 - 36.53% )/( (130073 + 133448)/ 2 )
=13699.3648/131760.5
=10.40 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=156617 - 46202 - ( 21060 - max(0, 81858 - 62200+21060))
=130073

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=158116 - 41525 - ( 21401 - max(0, 76134 - 59277+21401))
=133448

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Qol Holdings Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=20444/( ( (17865 + max(-17754, 0)) + (22199 + max(-19003, 0)) )/ 2 )
=20444/( ( 17865 + 22199 )/ 2 )
=20444/20032
=102.06 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(26850 + 12358 + 1932) - (46202 + 0 + 12692)
=-17754

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(25826 + 9966 + 2084) - (41525 + 0 + 15354)
=-19003

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Qol Holdings Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=14746/86933.325
=16.96 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qol Holdings Co EBIT Related Terms

Qol Holdings Co EBIT Historical Data

* Premium members only.

The historical data trend for Qol Holdings Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qol Holdings Co EBIT Chart

Qol Holdings Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9,788.00 9,673.00 8,969.00 13,063.00 14,746.00

Qol Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,416.00 3,670.00 3,648.00 2,317.00 5,111.00

Qol Holdings Co EBIT Competitor Comparison

For the Pharmaceutical Retailers subindustry, Qol Holdings Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qol Holdings Co EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Qol Holdings Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Qol Holdings Co's EV-to-EBIT falls into.


TSE:3034
89GF Score
Qol Holdings Co Ltd TSE:3034
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Qol Holdings Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円14,746 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円14,746 Mil mean?
Qol Holdings Co (TSE:3034) has a EBIT of 円14,746 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Qol Holdings Co.
Is Qol Holdings Co's EBIT too high?
Qol Holdings Co's current EBIT is 円14,746 Mil. Overall, Qol Holdings Co has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qol Holdings Co's EBIT compare to competitors?
Qol Holdings Co's EBIT of 円14,746 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Qol Holdings Co. Qol Holdings Co's current EBIT is 円14,746 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qol Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Qol Holdings Co (TSE:3034) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,274.64, compared to a current price of 円1,822.00 — trading 19.9% below its estimated fair value. The current EBIT is 円14,746 Mil. Qol Holdings Co's overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Qol Holdings Co (TSE:3034), the current EBIT is 円14,746 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Qol Holdings Co (TSE:3034) Overvalued in 2026?

Based on GuruFocus' analysis, Qol Holdings Co stock appears to be undervalued. The current stock price of 円1,822.00 is trading 19.9% below its estimated GF Value™ of 円2,274.64. GuruFocus considers Qol Holdings Co to be Modestly Undervalued.

Key valuation signals for TSE:3034:

  • EBIT: 円14,746 Mil
  • GF Value™: 円2,274.64 vs. price of 円1,822.00 (19.9% below fair value)
  • GF Score™: 89/100 with 1 warning sign

No single metric tells the full story. See the TSE:3034 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Qol Holdings Co Business Description

Address 4-3-1, Toranomon, 37th Floor, Shiroyama Trust Tower, Minato-ku, Tokyo, JPN, 105-8452
Qol Holdings Co Ltd provides pharmacy services under health insurance and sells pharmaceutical products. Its mission is to create healthy and comfortable living environments for everybody in those communities. The company operates through: Pharmacy and BPO segments. Under the Pharmacy segment the company puts customers first in-store development strategy, which is based on building one-on-one relationships with drug-prescribing clinics and hospitals in order to get the pharmacy services that include medical information. The BPO contracting segment includes clinical trials and projects and develops pamphlets and websites for medical institutions to promote sales of pharmaceutical products and provide advice on proper pharmaceutical product.
89GF Score

Get the complete analysis for TSE:3034

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,822.00
Price
円2,274.64
GF Value